Your Account
Filter Articles
Sort
Categories
- #EMSPVirtual2021
- Associate members
- Document
- EMSP Events
- EMSP Events|EMSP News
- EMSP News
- EMSP News|From Europe
- EMSP News|From Europe|Stakeholder Events
- EMSP News|MS Research
- EMSP News|Press Releases
- EMSP News|Young People with MS
- From Europe
- From Europe|Member News
- From Europe|Stakeholder Events
- From Europe|Young People with MS
- Full members
- Full members|Member News
- Member News
- Member News|Young People with MS
- MS Research
- News – EMSP
- News2
- Press Releases
- Project Updates
- Stakeholder Events
- Uncategorized
- Young People with MS
EU collaboration in health for better access: Taking stock and looking to the future
27.03.2019
The Patient Access Partnership (PACT) gathered a wide range of stakeholders at the MEP Interest Group on Access to Healthcare…
From laboratory to your medicine: EMA’s new booklet explains it all
27.03.2019
Have you ever wondered how a new medicine is approved for the treatment of your disease? We have the answer….
Event report: “Lifting the Burden of Neurological Disorders in Europe” panel discussion in the European Parliament
08.03.2019
The European Federation of Neurological Associations (EFNA) and the European Academy of Neurology (EAN) jointly organized an event entitled “Lifting…
21st State of Art Symposium around the challenges of MS treatment in Switzerland
08.03.2019
Paediatric MS and MS in old age were the two main topics neurologists explored at the 21st State of the…
More than 21,000 people call for action on ocrelizumab for Primary Progressive MS in the UK
08.03.2019
More than 21,000 people have signed a petition launched by the MS Society UK, calling for ocrelizumab to be made…
Oceans of Hope: sailing with MS in 2019
08.03.2019
We have previously featured the Oceans of Hope (OoH) yacht that circumnavigated the world in 2014. There were approximately 100…
